Scinovex
article Open AccessTop 1% cited

Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease

Circulation Research · 2001 · Vol. 89(1) · pp. E1–7
Mariuca VasaStephan FichtlschererAlexandra AicherKlaudia AdlerCarmen UrbichHans MartinAndreas M. ZeiherStefanie Dimmeler

Abstract

Recent studies provide increasing evidence that postnatal neovascularization involves bone marrow-derived circulating endothelial progenitor cells (EPCs). The regulation of EPCs in patients with coronary artery disease (CAD) is unclear at present. Therefore, we determined the number and functional activity of EPCs in 45 patients with CAD and 15 healthy volunteers. The numbers of isolated EPCs and circulating CD34/kinase insert domain receptor (KDR)-positive precursor cells were significantly reduced in patients with CAD by approximately 40% and 48%, respectively. To determine the influence of atherosclerotic risk factors, a risk factor score including age, sex, hypertension, diabetes, smoking, positive family history of CAD, and LDL cholesterol levels was used. The number of risk factors was significantly correlated with a reduction of EPC levels (R=-0.394, P=0.002) and CD34-/KDR-positive cells (R=-0.537, P<0.001). Analysis of the individual risk factors demonstrated that smokers had significantly reduced levels of EPCs (P<0.001) and CD34-/KDR-positive cells (P=0.003). Moreover, a positive family history of CAD was associated with reduced CD34-/KDR-positive cells (P=0.011). Most importantly, EPCs isolated from patients with CAD also revealed an impaired migratory response, which was inversely correlated with the number of risk factors (R=-0.484, P=0.002). By multivariate analysis, hypertension was identified as a major independent predictor for impaired EPC migration (P=0.043). The present study demonstrates that patients with CAD revealed reduced levels and functional impairment of EPCs, which correlated with risk factors for CAD. Given the important role of EPCs for neovascularization of ischemic tissue, the decrease of EPC numbers and activity may contribute to impaired vascularization in patients with CAD. The full text of this article is available at http://www.circresaha.org.

Angiogenesis and VEGF in CancerCongenital heart defects researchCancer, Hypoxia, and MetabolismCD34MedicineCoronary artery diseaseProgenitor cellInternal medicineEndothelial progenitor cellKinase insert domain receptorNeovascularizationBone marrowEndocrinology

MeSH terms

AC133 AntigenCell CountCell MovementCells, CulturedCoronary Artery DiseaseCoronary DiseaseEndothelium, VascularFemaleGlycoproteinsHematopoietic Stem CellsHumansHypertensionMaleMiddle AgedNeovascularization, Pathologic

Funding

  • American Heart Association
  • National Institutes of Health
Citations
2,323
FWCI
18.40
field-weighted impact
References
32
Percentile
100%
vs. same field & year
Citations per year
Cited by
Endothelial Progenitor Cells
Circulation Research · 2004 · 2,355 citations
Circulating endothelial cells
Thrombosis and Haemostasis · 2005 · 388 citations
Assessing Identity, Phenotype, and Fate of Endothelial Progenitor Cells
Arteriosclerosis Thrombosis and Vascular Biology · 2008 · 745 citations
Endothelial Progenitor Cells
Arteriosclerosis Thrombosis and Vascular Biology · 2003 · 741 citations
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Advanced Drug Delivery Reviews · 2003 · 3,325 citations
Hyperbaric Oxygen: Its Mechanisms and Efficacy
Plastic & Reconstructive Surgery · 2011 · 564 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.